On October 4-5, 2022 ASBM Advisory Board Chair Philip Schneider participated in the World Drug Safety Congress Americas 2022, held in Boston, MA. The annual pharmacovigilance (PV) conference bills itself as “the largest commercial gathering of PV professionals in the world.

During the two-day conference, Prof. Schneider chaired both the Global PV Track and Advanced Therapies Track. 

In addition to chairing the Global PV track Professor Schneider also presented on the role of distinguishable biologic nomenclature in improving global pharmacovigilance. Distinct biologic nomenclature, he argued, promotes the more accurate tracking of biologic medicines, including biosimilars. In addition, a harmonized system such as that proposed by the WHO, would facilitate the sharing of that information internationally.

Learn more about the World Drug Safety Congress here.